Indaptus Therapeutics, Inc. (INDP)
NASDAQ·Healthcare·Biotechnology
$3.39
+1.35%
Mkt Cap $357.85M
No analyst coverage available
We don't have analyst ratings or price target data for Indaptus Therapeutics, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.